经济观察网讯 ...

Neuberg Diagnostics, one of India’s leading diagnostics chains, has secured Rs 940 crores in investment from Kotak Alt, ...

Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...

British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the ...

London open The FTSE 100 is expected to open 14 points lower on Friday, having closed up 0.83% on Thursday at 8,319.69.

Neuberg Diagnostics, promoted by GSK Velu, is planning to use the pre-initial public offering fundraise to boost its merger ...

Kotak Strategic Situations India Fund II invests ₹940 crore in Neuberg Diagnostics for expansion and IPO preparation.

RSV疫苗再遭“打击”。 日前，FDA 发布公告，要求辉瑞和GSK对其已被批准上的RSV疫苗的标签进行修改，添加有关吉兰-巴雷综合征风险的新警告。 CSO企业在制药的路上越走越远。 1月8日，康哲药业宣布，通过全资附属公司与Alpha ...

Kotak Strategic Situations India Fund II, which is managed by Kotak Alternate Asset Managers Ltd, said Friday that it ...

截至2025年1月，卡替拉韦长效方案是国内首个且唯一获国家药监局批准上市的用于HIV暴露前预防的长效注射针剂。作为一种HIV-1整合酶链转移抑制剂 (INSTI)，卡替拉韦长效方案仅需每年注射最少6次即可实现HIV暴露前预防。使用者将在前两个月内接受每月600mg (3ml)的起始注射，随后每两个月接受一次600mg (3ml)的继续注射。

Kotak Strategic Situations India Fund II has invested Rs 940 Crore in Neuberg Diagnostics to support its inorganic expansion ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...